Resting-state functional magnetic resonance imaging (fMRI) is a method of functional brain imaging (i.e., the measurement of the aspect of a brain area by images) that can be used to evaluate regional interactions that occur when a subject is resting. The fMRI has highlighted the rich structure of brain activity in absence of a task or stimulus. […]
Author Archives: Luca Maggioni
38 posts published by Luca Maggioni
Rett Syndrome meeting in Santander in July ’17
The International University Menéndez y Pelayo organizes in Santander from 10 to 12 July 2017 a course on the latest developments in the research on the Rett Syndrome. “Rett syndrome, current situation and trends in research” The aim of this meeting on the Rett Syndrome is to exchange knowledge about this pathology, bringing together the […]
The diseases of the synaptic vesicles open the way to a new group of neurometabolic diseases
The Inborn Errors of Metabolism (IEM) have normally been considered as the result of errors at the genetic level affecting the biochemical pathways of small molecules such as the neurotransmitters glycine, glutamate, GABA, biogenic amines, etc. The altered concentration of such molecules in the Cerebrospinal Fluid (CSF) have always been used as a diagnostic biomarker […]
RETT SYNDROME: FROM THE PATIENT TO THE LABORATORY, A ROUND TRIP
Updating Day in the research carried out on Rett Syndrome by the HSJD and its collaborators.
Central Serotonin Receptor 7 constitutes a potential therapeutic target for Rett Syndrome
Rett syndrome is a neurodevelopment disorder affecting around 1 out of 10,000 girls, usually due to de novo mutations in the X-located gene MECP2. It is a complex disorder, both clinically and at a molecular level, and is typically characterized by a neurodevelopment regression starting at age 6 to 18 months after a normal early […]
Page 3 of 8
